Opinion: Congress urged to increase oversight of 340B drug pricing program

This opinion piece calls on Congress to implement stricter accountability measures for the 340B drug pricing program. The author argues that the program needs reform to ensure it effectively serves vulnerable patients.

We have not fully decoded this article yet, so read the full story at Times of San Diego.